ACOG 2022 – New Findings on Elagolix + Add Back Therapy for Endometriosis
Eli Frakes, PhD, Scientific Director of Women’s Health in US Medical Affairs at AbbVie discusses data that AbbVie presented at the American College of Obstetricians and Gynecologists (ACOG) Clinical and Scientific Meeting 2022 on the use of ORILISSA ® (elagolix) 200mg BID with hormonal add-back therapy, or the “adding back” of a small amount of estradiol and/or progestogens to help reduce potential side effects of treatment, for moderate-to-severe endometriosis-associated pain (EAP).
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Therapy. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Therapy and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Therapy?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Eli Frakes is the Scientific Director of Women’s Health in US Medical Affairs at AbbVie. He has broad medical affairs experience supporting both US and global markets. Eli obtained his PhD in pharmacology with a focus in basic science of pain mechanisms from the University of Iowa and completed an Executive Certificate in the Business of Life Sciences at the Kelley Business School of Indiana University. He graduated from Buena Vista University with a double major in Biology and Chemistry.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
